A conceptual framework for the molecular pathogenesis of progressive kidney disease

Pediatric Nephrology

Volumn 25, Issue 11, 2010, Pages 2223-2230

  Schnaper, H William ^a,b   Hubchak, Susan C ^a,b   Runyan, Constance E ^a,b   Browne, James A ^a,b   Finer, Gal ^a,b   Liu, Xiaoying ^a,b   Hayashida, Tomoko ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b CHILDREN'S MEMORIAL HOSPITAL   (United States)

Author keywords

Chronic kidney disease; Fibrosis; Kidney; Signal transduction

Indexed keywords

ANGIOTENSIN II; BASIC FIBROBLAST GROWTH FACTOR; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; INTERLEUKIN 13; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR; SULODEXIDE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; APOPTOSIS; CELL DEATH; CELL LOSS; CELL REGENERATION; CELLULAR IMMUNITY; CHRONIC KIDNEY DISEASE; CHRONIC PYELONEPHRITIS; CONCEPTUAL FRAMEWORK; CYTOKINE RESPONSE; DISEASE COURSE; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; FOCAL GLOMERULOSCLEROSIS; GENETIC PREDISPOSITION; GLOMERULOPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FIBROSIS; KIDNEY POLYCYSTIC DISEASE; KIDNEY SCAR; KIDNEY TUBULOGLOMERULAR FEEDBACK; MINIMAL CHANGE GLOMERULONEPHRITIS; MOLECULAR INTERACTION; NEPHRON; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEINURIA; REVIEW; STEADY STATE;

CYTOKINES; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY GLOMERULUS; MODELS, BIOLOGICAL; NEPHRONS; PROTEINURIA;

EID: 77957261122     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1503-4     Document Type: Review

References (52)

1. J Coresh E Selvin LA Stevens J Manzi JW Kusek P Eggers F Van Lente AS Levey 2007 Prevalence of chronic kidney disease in the United States JAMA 298 2038 2047 1:CAS:528:DC%2BD2sXht1yjsLnM 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
2. RJ Glassock C Winearls 2008 Screening for CKD with eGFR: doubts and dangers Clin J Am Soc Nephrol 3 1563 1568 10.2215/CJN.00960208 18667744
3. K Thurau JW Boylan 1976 Acute renal success The unexpected logic of oliguria in acute renal failure. Am J Med 61 308 315 1:CAS:528: DyaE28Xlt1SqsLY%3D
4. R Ross 1999 Atherosclerosis-an inflammatory disease N Engl J Med 340 115 126 1:STN:280:DyaK1M%2FptFSqtQ%3D%3D 10.1056/NEJM199901143400207 9887164 (Pubitemid 29054847)
5. NS Bricker LG Fine M Kaplan M Epstein JJ Bourgoignie A Light 1978 "Magnification phenomenon" in chronic renal disease N Engl J Med 299 1287 1293 1:CAS:528:DyaE1MXjslWlsg%3D%3D 10.1056/NEJM197812072992307 714096 (Pubitemid 9115798)
6. JL Barnes RR Hastings MA De la Garza 1994 Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis Am J Pathol 145 585 597 1:CAS:528: DyaK2cXmslyisrk%3D 8080041
7. RJ Shalhoub 1974 Pathogenesis of lipoid nephrosis: a disorder of T-cell function Lancet 2 556 560 1:STN:280:DyaE2M%2Fmt12qsA%3D%3D 10.1016/S0140- 6736(74)91880-7 4140273
8. HW Schnaper 1989 The immune system in minimal change nephrotic syndrome Pediatr Nephrol 3 101 110 1:STN:280:DyaK3M%2Fgt1SqsQ%3D%3D 10.1007/BF00859637 2702078 (Pubitemid 19043603)
9. D Sahali A Pawlak A Valanciute P Grimbert P Lang P Remy A Bensman G Guellaen 2002 A novel approach to investigation of the pathogenesis of active minimal-change nephrotic syndrome using subtracted cDNA library screening J Am Soc Nephrol 13 1238 1247 1:CAS:528:DC%2BD38XktFaitr4%3D 11961011 (Pubitemid 34441404)
10. CE Araya CH Wasserfall TM Brusko W Mu MS Segal RJ Johnson EH Garin 2006 A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome Pediatr Nephrol 21 603 610 10.1007/s00467-006-0026-5 16525836
11. KW Lai CL Wei LK Tan PH Tan GS Chiang CG Lee SC Jordan HK Yap 2007 Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats J Am Soc Nephrol 18 1476 1485 1:CAS:528:DC%2BD2sXls1Glu78%3D 10.1681/ASN.2006070710 17429054 (Pubitemid 46717514)
12. JM Heslan AI Branellec Y Pilatte P Lang G Lagrue 1991 Differentiation between vascular permeability factor and IL-2 in lymphocyte supernatants from patients with minimal-change nephrotic syndrome Clin Exp Immunol 86 157 162 1:STN:280:DyaK38%2Fgs1amsg%3D%3D 10.1111/j.1365-2249.1991.tb05789.x 1914229
13. EH Garin L West W Zheng 1997 Effect of interleukin-8 on glomerular sulfated compounds and albuminuria Pediatr Nephrol 11 274 279 1:STN:280:DyaK2szks1Omtw%3D%3D 10.1007/s004670050276 9203172 (Pubitemid 27230807)
14. M Morales-Ruiz D Fulton G Sowa LR Languino Y Fujio K Walsh WC Sessa 2000 Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt Circ Res 86 892 896 1:CAS:528:DC%2BD3cXjtVehtbc%3D 10785512 (Pubitemid 30246987)
15. SH Sung FN Ziyadeh A Wang PE Pyagay YS Kanwar S Chen 2006 Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice J Am Soc Nephrol 17 3093 3104 1:CAS:528:DC%2BD28Xht1yjtbrK 10.1681/ASN.2006010064 16988063 (Pubitemid 44707769)
16. CC Moller J Flesche J Reiser 2009 Sensitizing the slit diaphragm with TRPC6 ion channels J Am Soc Nephrol 20 950 953 1:CAS:528:DC%2BD1MXlvFKqsbk%3D 10.1681/ASN.2008030329 18784209
17. L Barisoni HW Schnaper JB Kopp 2007 A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases Clin J Am Soc Nephrol 2 529 542 10.2215/CJN.04121206 17699461
18. L Barisoni HW Schnaper JB Kopp 2009 Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy Arch Pathol Lab Med 133 201 216 19195964
19. M Schiffer M Bitzer IS Roberts JB Kopp P ten Dijke P Mundel EP Bottinger 2001 Apoptosis in podocytes induced by TGF-beta and Smad7 J Clin Invest 108 807 816 1:CAS:528:DC%2BD3MXmvV2ntLg%3D 11560950 (Pubitemid 32880291)
20. HW Schnaper T Hayashida SC Hubchak AC Poncelet 2003 TGF-beta signal transduction and mesangial cell fibrogenesis Am J Physiol Renal Physiol 284 F243 F252 1:CAS:528:DC%2BD3sXhtlOqtLo%3D 12529270 (Pubitemid 36114687)
21. Y Liu 2004 Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention J Am Soc Nephrol 15 1 12 1:CAS:528:DC%2BD2cXhs1ahtA%3D%3D 10.1097/01.ASN.0000106015. 29070.E7 14694152 (Pubitemid 38020692)
22. A Shimizu N Yamanaka 1993 Apoptosis and cell desquamation in repair process of ischemic tubular necrosis Virchows Arch B Cell Pathol Incl Mol Pathol 64 171 180 1:STN:280:DyaK2c%2FmtFejtA%3D%3D 10.1007/BF02915110 8242176 (Pubitemid 23281667)
23. M Sato Y Muragaki S Saika AB Roberts A Ooshima 2003 Targeted disruption of TGF-beta1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction J Clin Invest 112 1486 1494 1:CAS:528:DC%2BD3sXptFWqt7k%3D 14617750 (Pubitemid 38056275)
24. M Schiffer LE Schiffer A Gupta AS Shaw IS Roberts P Mundel EP Bottinger 2002 Inhibitory Smads and TGF-beta signaling in glomerular cells J Am Soc Nephrol 13 2657 2666 1:CAS:528:DC%2BD38XnvF2ls7k%3D 10.1097/01.ASN.0000033276. 06451.50 12397035 (Pubitemid 35216034)
25. G Wolf S Chen DC Han FN Ziyadeh 2002 Leptin and renal disease Am J Kidney Dis 39 1 11 1:CAS:528:DC%2BD38XlslKjtA%3D%3D 10.1053/ajkd.2002.29865 11774095 (Pubitemid 34062489)
26. W Qi S Twigg X Chen TS Polhill P Poronnik RE Gilbert CA Pollock 2005 Integrated actions of transforming growth factor-beta1 and connective tissue growth factor in renal fibrosis Am J Physiol Renal Physiol 288 F800 F809 1:CAS:528:DC%2BD2MXjtlOqtLg%3D 10.1152/ajprenal.00179.2004 15536170 (Pubitemid 40381749)
27. JA Bassuk R Pichler JD Rothmier J Pippen K Gordon RL Meek AD Bradshaw D Lombardi TP Strandjord M Reed EH Sage WG Couser R Johnson 2000 Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis Kidney Int 57 117 128 1:CAS:528:DC%2BD3cXivFOlurg%3D 10.1046/j.1523-1755.2000.00811.x 10620193 (Pubitemid 30227759)
28. DS Goumenos S Tsakas AM El Nahas S Alexandri S Oldroyd P Kalliakmani JG Vlachojannis 2002 Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria Nephrol Dial Transplant 17 2145 2152 1:CAS:528:DC%2BD38XptlOhsLc%3D 10.1093/ndt/17.12.2145 12454225 (Pubitemid 35446670)
29. G Guo J Morrissey R McCracken T Tolley H Liapis S Klahr 2001 Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis Am J Physiol Renal Physiol 280 F777 F785 1:CAS:528:DC%2BD3MXjsVCjsrg%3D 11292619 (Pubitemid 32441252)
30. V Ophascharoensuk CM Giachelli K Gordon J Hughes R Pichler P Brown L Liaw R Schmidt SJ Shankland CE Alpers WG Couser RJ Johnson 1999 Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis Kidney Int 56 571 580 1:CAS:528:DyaK1MXltlOgsr0%3D 10.1046/j.1523-1755.1999.00580.x 10432396 (Pubitemid 29353155)
31. Y Ozawa H Kobori Y Suzaki LG Navar 2007 Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions Am J Physiol Renal Physiol 292 F330 F339 1:CAS:528:DC%2BD2sXisFGhtb4%3D 10.1152/ajprenal. 00059.2006 16804106 (Pubitemid 46105273)
32. J Floege W Kriz M Schulze M Susani D Kerjaschki A Mooney WG Couser KM Koch 1995 Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy J Clin Invest 96 2809 2819 1:CAS:528:DyaK28XmtVegsQ%3D%3D 10.1172/JCI118351 8675651
33. F Terzi M Burtin M Hekmati P Federici G Grimber P Briand G Friedlander 2000 Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury J Clin Invest 106 225 234 1:CAS:528:DC%2BD3cXkvFWgsrs%3D 10.1172/JCI8315 10903338 (Pubitemid 30483126)
34. LA Haseley C Hugo MA Reidy RJ Johnson 1999 Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis Kidney Int 56 964 972 1:CAS:528:DyaK1MXlvF2gur4%3D 10.1046/j.1523-1755.1999.00641.x 10469364 (Pubitemid 29411723)
35. T Oikawa M Freeman W Lo DE Vaughan A Fogo 1997 Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition Kidney Int 51 164 172 1:STN:280: DyaK2s7kvV2jtw%3D%3D 10.1038/ki.1997.20 8995730 (Pubitemid 27064534)
36. A Wang FN Ziyadeh EY Lee PE Pyagay SH Sung SA Sheardown NJ Laping S Chen 2007 Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria Am J Physiol Renal Physiol 293 F1657 F1665 1:CAS:528:DC%2BD2sXhtlGhtrjE 10.1152/ajprenal.00274.2007 17804483 (Pubitemid 350086003)
37. P Singh A Deng RC Blantz SC Thomson 2009 Unexpected effect of angiotensin AT1 receptor blockade on tubuloglomerular feedback in early subtotal nephrectomy Am J Physiol Renal Physiol 296 F1158 F1165 1:CAS:528: DC%2BD1MXlvFanu7o%3D 10.1152/ajprenal.90722.2008 19211684
38. I Ichikawa A Fogo 1996 Focal segmental glomerulosclerosis Pediatr Nephrol 10 374 391 1:STN:280:DyaK28zosVGhsw%3D%3D 8792409 (Pubitemid 26171093)
39. MP Schlaich D Schmitt C Ott BM Schmidt RE Schmieder 2008 Basal nitric oxide synthase activity is a major determinant of glomerular haemodynamics in humans J Hypertens 26 110 116 1:CAS:528:DC%2BD2sXhsVCjsrjJ 10.1097/HJH. 0b013e3282f1a93e 18090547 (Pubitemid 350294855)
40. M Ozeki H Nagasu M Satoh T Namikoshi Y Haruna N Tomita T Sasaki N Kashihara 2009 Reactive oxygen species mediate compensatory glomerular hypertrophy in rat uninephrectomized kidney J Physiol Sci 59 397 404 1:CAS:528:DC%2BD1MXht1ajsrbM 10.1007/s12576-009-0048-4 19593678
41. Eberhardt W, Pfeilschifter J (2007) Nitric oxide and vascular remodeling: spotlight on the kidney. Kidney Int Suppl 106:S9-S16 (Pubitemid 47172556)
42. W Kriz M LeHir 2005 Pathways to nephron loss starting from glomerular diseases-insights from animal models Kidney Int 67 404 419 10.1111/j.1523-1755. 2005.67097.x 15673288 (Pubitemid 40139832)
43. DH Lovett RJ Johnson HP Marti J Martin M Davies WG Couser 1992 Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis Am J Pathol 141 85 98 1:CAS:528:DyaK38Xls12gsLs%3D 1321565
44. F Oktem A Sirin I Bilge S Emre B Agachan T Ispir 2004 ACE I/D gene polymorphism in primary FSGS and steroid-sensitive nephrotic syndrome Pediatr Nephrol 19 384 389 10.1007/s00467-003-1398-4 14986085 (Pubitemid 38477400)
45. GH Tesch 2008 MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy Am J Physiol Renal Physiol 294 F697 F701 1:CAS:528:DC%2BD1cXkvVyktrc%3D 10.1152/ajprenal.00016.2008 18272603
46. P August V Sharma R Ding JE Schwartz M Suthanthiran 2009 Transforming growth factor beta and excess burden of renal disease Trans Am Clin Climatol Assoc 120 61 72 19768163
47. Schnaper HW, Robson AM, Kopp JB (2006) Nephrotic syndrome: minimal change nephropathy, focal segmental glomerulosclerosis and collapsing glomerulopathy. In: Schrier RW (ed) Diseases of the kidney and urinary tract, 8th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1585-1673
48. JB Kopp MW Smith GW Nelson RC Johnson BI Freedman DW Bowden T Oleksyk LM McKenzie H Kajiyama TS Ahuja JS Berns W Briggs ME Cho RA Dart PL Kimmel SM Korbet DM Michel MH Mokrzycki JR Schelling E Simon H Trachtman D Vlahov CA Winkler 2008 MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis Nat Genet 40 1175 1184 1:CAS:528:DC%2BD1cXhtFKht77E 10.1038/ng.226 18794856
49. Y Motoyoshi T Matsusaka A Saito I Pastan TE Willnow S Mizutani I Ichikawa 2008 Megalin contributes to the early injury of proximal tubule cells during nonselective proteinuria Kidney Int 74 1262 1269 1:CAS:528:DC%2BD1cXhtlSkt7jN 10.1038/ki.2008.405 18769366
50. M Rossini T Naito H Yang M Freeman E Donnert LJ Ma SR Dunn K Sharma AB Fogo 2010 Sulodexide ameliorates early but not late kidney disease in models of radiation nephropathy and diabetic nephropathy Nephrol Dial Transplant 10.1093/ndt/gfp724
51. M Mauer B Zinman R Gardiner S Suissa A Sinaiko T Strand K Drummond S Donnelly P Goodyer MC Gubler R Klein 2009 Renal and retinal effects of enalapril and losartan in type 1 diabetes N Engl J Med 361 40 51 1:CAS:528: DC%2BD1MXotV2hu70%3D 10.1056/NEJMoa0808400 19571282
52. P Fioretto MW Steffes DE Sutherland FC Goetz M Mauer 1998 Reversal of lesions of diabetic nephropathy after pancreas transplantation N Engl J Med 339 69 75 1:STN:280:DyaK1czgslKhsA%3D%3D 10.1056/NEJM199807093390202 9654536 (Pubitemid 28304880)